Growth improves with oral immunotherapy
September 08, 2025 3 min read Add topic to email alerts Receive an email when...
oral
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness
Single-cell multi-omics analysis of pr CD4+ cells from individuals in the POISED studyThe POISED trial design3 is illustrated in Fig....
Burks and Keet Publish Editorial on Oral Immunotherapy for High Threshold Peanut Allergy
Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, professor of pediatrics, Division of...
Omalizumab treats multi-food allergy better than oral immunotherapy
News ReleaseMonday, March 3, 2025 High rate of oral immunotherapy side effects in NIH trial explains superiority of omalizumab.A clinical...
